SCR-LIP-000601 · Claim · JSON legível por máquina →
A ultrassonografia é usada para medir a espessura e a rigidez subcutâneas no acompanhamento do tratamento do lipedema, separadamente do diagnóstico.
Proposição geral consolidada a partir de 3 claims anteriores de artigo único; o resultado de cada estudo aparece como achado.
Claim em resumo
- Tipo
- associação clínica
- Estado do conhecimento
- Emergente
- Certeza da evidência
- baixa (GRADE)
- Evidência
- 3 fonte(s)
- Responde a
- 1 pergunta(s)
- Datas
- 2026-11-20 → 2026-11-20
Evidência estruturada, compilada por máquina — não é um veredito.
Evidência ao longo do tempo
Evidência (3)
- Optimizing Liposuction in Lipedema Patients: A Novel Approach with Perioperative and Intraoperative Ultrasound. — Munoz J, Fons S, Fabbri M. (2026) ✓ verificado — consistente · case series · 2026 · confiança da leitura: high
“Perioperative US was used to measure the thickness of the superficial subcutaneous fat (D1) and the deep fat layer (D2) at a standardized anatomical site.”
In 24 women undergoing liposuction, perioperative ultrasound showed superficial subcutaneous fat (D1) decreasing from 9.9 mm to 6.3 mm.
The article uses ultrasound to measure and monitor fat reduction during liposuction, not to diagnose or classify lipedema; it is on-topic regarding ultrasound in lipedema but does not test diagnostic/classification utility. - Clinical, ultrasound, elastography and bioimpedance changes after radial extracorporeal shock wave therapy in patients with lipedema: A prospective within-patient study. — Novo Rigueiro M, Bravo González M, Prado Moraña T, Pena Dubra A, Villarroel Comesaña S, Navarro Núñez P, Villamayor Blanco B, Novo Veleiro I. (2026) ✓ verificado — consistente · case series · 2026 · confiança da leitura: high
“Ultrasound and elastography were used to evaluate subcutaneous tissue thickness and stiffness at predefined leg and thigh sites”
Ultrasound and elastography measured subcutaneous thickness and stiffness at predefined leg and thigh sites to evaluate changes after radial shock wave therapy.
Ultrasound/elastography were used for tissue measurement and treatment monitoring, not to diagnose or classify lipedema; diagnosis was clinical. The article is on-topic regarding ultrasound imaging in lipedema but does not test its diagnost - Serrapeptase After Liposuction for Lipedema: Limited Evidence for Antifibrotic Efficacy. — Bruno A, Saccoccio V. (2026) ✓ verificado — consistente · cohort · 2026 · confiança da leitura: high
“The primary outcome was tissue stiffness measured by quantitative ultrasound elastography (QUS). Secondary outcomes included B-mode ultrasonography, patient-reported pain (VAS), and clinical assessment of induration.”
In 50 women after tumescent liposuction, quantitative ultrasound elastography and B-mode measured postoperative stiffness (e.g., 14.8 +/- 3.1 kPa) and fibrotic changes to assess serrapeptase.
The article uses ultrasound (QUS and B-mode) to assess postoperative tissue stiffness/fibrosis in lipedema patients, but does not test ultrasound's ability to diagnose or classify lipedema itself; it studies serrapeptase efficacy, making it
Contexto (PECO)
Responde a estas perguntas
Lacunas e ressalvas
Histórico de mudanças
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000003